These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31386307)

  • 1. Han Chinese family with early-onset Parkinson's disease carries novel compound heterozygous mutations in the PARK2 gene.
    Huang T; Gao CY; Wu L; Gong PY; Wang JZ; Tian YY; Zhang YD
    Brain Behav; 2019 Sep; 9(9):e01372. PubMed ID: 31386307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel compound heterozygous mutations in the
    Shi Y; Kawakami H; Zang W; Li G; Zhang J; Xu C
    Brain Behav; 2018 Jan; 8(1):e00901. PubMed ID: 29568695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic study of a Chinese pedigree with early onset Parkinson's disease caused by novel compound heterozygous mutations in
    Zhang L; Luo AD; Pan CY; Liu M; Liao SS
    Ibrain; 2021 Jun; 7(2):108-112. PubMed ID: 37786907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Exon Dosage Using Multiplex Ligation-Dependent Probe Amplification in Chinese Patients with Early-Onset Parkinson's Disease.
    Lin Y; Zeng YF; Cai NQ; Lin XZ; Wang N; He J
    Eur Neurol; 2019; 81(5-6):246-253. PubMed ID: 31618739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic study of a Parkinson's disease pedigree caused by compound heterozygous mutations in PARK2 gene].
    Chen M; Cen Z; Chen Y; Zheng X; Xie F; Chen S; Luo W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Dec; 35(6):815-818. PubMed ID: 30512153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable PARK2 Mutations Cause Early-Onset Parkinson's Disease in a Small Restricted Population.
    Ben-Shachar S; Afawi Z; Masalha R; Badarny S; Neiman T; Pavzner D; Bar-Shira A; Orr-Urtreger A
    J Mol Neurosci; 2017 Oct; 63(2):216-222. PubMed ID: 28913705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis of PARK2 in a Uyghur family with early-onset Parkinson's disease in Xinjiang, China.
    Li H; Yusufujiang A; Naser S; Zhu Y; Maimaiti M; He X; Bu J; Meng X; Wang M; Li J; Dina B; Yang L; Nayi Z; Dang H; Wang C; Amiti D; Aji A; Yusufu N; Jiao Y; Duan F
    J Neurol Sci; 2014 Jul; 342(1-2):21-4. PubMed ID: 24831986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole exome sequencing identified a new compound heterozygous PRKN mutation in a Chinese family with early-onset Parkinson's disease.
    Li T; Kou D; Cui Y; Le W
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32391545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breakpoint mapping of 13 large parkin deletions/duplications reveals an exon 4 deletion and an exon 7 duplication as founder mutations.
    Elfferich P; Verleun-Mooijman MC; Maat-Kievit JA; van de Warrenburg BP; Abdo WF; Eshuis SA; Leenders KL; Hovestadt A; Zijlmans JC; Stroy JP; van Swieten JC; Boon AJ; van Engelen K; Verschuuren-Bemelmans CC; Lesnik-Oberstein SA; Tassorelli C; Lopiano L; Bonifati V; Dooijes D; van Minkelen R
    Neurogenetics; 2011 Nov; 12(4):263-71. PubMed ID: 21993715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic mutations in early-onset Parkinson's disease Mexican patients: molecular testing implications.
    Monroy-Jaramillo N; Guerrero-Camacho JL; Rodríguez-Violante M; Boll-Woehrlen MC; Yescas-Gómez P; Alonso-Vilatela ME; López-López M
    Am J Med Genet B Neuropsychiatr Genet; 2014 Apr; 165B(3):235-44. PubMed ID: 24677602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase analysis identifies compound heterozygous deletions of the PARK2 gene in patients with early-onset Parkinson disease.
    Kim SY; Seong MW; Jeon BS; Kim SY; Ko HS; Kim JY; Park SS
    Clin Genet; 2012 Jul; 82(1):77-82. PubMed ID: 21534944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of PARK2 gene exon rearrangements in Russian patients with sporadic Parkinson's disease.
    Semenova EV; Shadrina MI; Slominsky PA; Ivanova-Smolenskaya IA; Bagyeva G; Illarioshkin SN; Limborska SA
    Mov Disord; 2012 Jan; 27(1):139-42. PubMed ID: 21915905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second mutation in PARK2 is absent in patients with sporadic Parkinson's disease and heterozygous exonic deletions/duplications in parkin gene.
    Shulskaya MV; Shadrina MI; Fedotova EY; Abramycheva NY; Limborska SA; Illarioshkin SN; Slominsky PA
    Int J Neurosci; 2017 Sep; 127(9):781-784. PubMed ID: 27798970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic instability in the PARK2 locus is associated with Parkinson's disease.
    Ambroziak W; Koziorowski D; Duszyc K; Górka-Skoczylas P; Potulska-Chromik A; Sławek J; Hoffman-Zacharska D
    J Appl Genet; 2015 Nov; 56(4):451-461. PubMed ID: 25833766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound heterozygous mutations in PARK2 causing early-onset Parkinson disease: A case report.
    Fang YQ; Mao F; Zhu MJ; Li XH
    Medicine (Baltimore); 2019 Feb; 98(5):e14228. PubMed ID: 30702579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of mutations in the PARK2 gene in Serbian patients with Parkinson's disease.
    Jankovic MZ; Dobricic V; Kresojevic N; Markovic V; Petrovic I; Svetel M; Pekmezovic T; Novakovic I; Kostic V
    J Neurol Sci; 2018 Oct; 393():27-30. PubMed ID: 30099245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel compound heterozygous of PARKIN causes early-onset Parkinson's disease.
    Yu LH; Peng GP; Yuan Y; Liu XY; Ji F; Li Y; He FP; Luo BY; Ke Q
    Neurosci Lett; 2021 Jan; 744():135597. PubMed ID: 33373675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exonic rearrangements in the known Parkinson's disease-causing genes are a rare cause of the disease in South African patients.
    van der Merwe C; Carr J; Glanzmann B; Bardien S
    Neurosci Lett; 2016 Apr; 619():168-71. PubMed ID: 27001088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PARK2 mutations and clinical features in a Chinese population with early-onset Parkinson's disease.
    Chan DK; Mok V; Ng PW; Yeung J; Kwok JB; Fang ZM; Clarke R; Wong L; Schofield PR; Hattori N
    J Neural Transm (Vienna); 2008 May; 115(5):715-9. PubMed ID: 18188499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of exon dosage using MLPA in South African Parkinson's disease patients.
    Keyser RJ; Lombard D; Veikondis R; Carr J; Bardien S
    Neurogenetics; 2010 Jul; 11(3):305-12. PubMed ID: 20013014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.